Centerspace (CSR) is not a strong buy at the moment for a beginner investor with a long-term strategy. The stock shows limited positive momentum, and while hedge funds are buying, the financial performance and lack of clear catalysts do not strongly support immediate investment. Holding off for better clarity or stronger signals is advisable.
The MACD is slightly positive but contracting, RSI is neutral at 41.264, and moving averages are converging. The stock is trading near its pivot level of 62.258, with resistance at 63.592 and support at 60.925. No strong technical signals indicate a clear trend.

Hedge funds are significantly increasing their buying activity, up 1474.48% over the last quarter.
No recent news or events to act as a catalyst. Insiders are neutral, and there is no recent congress trading data. Analyst sentiment remains neutral, with no strong upgrades or downgrades.
In Q4 2025, revenue increased slightly by 0.32% YoY to $66.62M. Net income improved significantly but remains negative at -$18.43M, with EPS also negative at -1.1. Gross margin slightly decreased to 16.57%.
Piper Sandler raised the price target to $69 from $66 but maintained a Neutral rating. The company is pausing new projects and focusing on strategic alternatives, which may impact growth.